J.M.W. Chan et al. / Tetrahedron 67 (2011) 4306e4312
4311
K3PO4 (0.23 mL, 7.5 equiv of base), and 1-bromo-4-tert-butylben-
zene (0.014 mL, 0.090 mmol, 1 equiv). The mixture was stirred
under nitrogen at 60 ꢀC for 4 h. The crude product was purified by
flash column chromatography (SiO2; hexanes) to afford 7a as an off-
white solid (14.4 mg, 64% over two steps). 1H NMR (400 MHz,
a white tacky solid (21.9 mg, 70% over two steps). 1H NMR
(400 MHz, CD2Cl2,
ppm): 7.97 (1H, d, J¼8.4 Hz), 7.76 (2H, d,
J¼8.4 Hz), 7.50e7.60 (3H, m), 7.20e7.32 (7H, m), 6.69 (1H, s), 2.33
(3H, s). 13C NMR (400 MHz, CD2Cl2,
ppm): 145.9, 135.6, 135.3,
131.3, 130.4, 127.3, 126.9, 125.0, 123.8, 121.9, 113.9, 109.6, 21.8.
HRMS: calcd: 347.0980 (M)þ, found: 347.0986.
d
d
CDCl3,
(1H, d, J¼8.4 Hz), 7.53 (2H, d, J¼6.4 Hz), 7.30 (2H, m), 7.03 (1H, s),
1.42 (9H, s). 13C NMR (400 MHz, CDCl3,
ppm): 156.3, 155.0, 152.0,
d
ppm): 7.86 (2H, d, J¼6.4 Hz), 7.63 (1H, d, J¼6.8 Hz), 7.57
d
4.6.13. 1-Tosyl-2-(40-trifluoromethylphenyl)indole
according to General procedure using Pd(OAc)2 (0.9 mg,
(8c). Prepared
129.5, 127.9, 125.9, 124.9, 124.2, 123.0, 120.9, 111.3, 100.9, 35.0, 31.4.
HRMS: calcd: 250.1358 (M)þ, found: 250.1362.
C
0.0045 mmol, 5 mol %), SPhos (3.1 mg, 0.0090 mmol, 10 mol %), 3.0 M
aqueous K3PO4 (0.23 mL, 7.5 equiv of base), and 4-chlorobenzotri-
fluoride (0.012 mL, 0.090 mmol, 1 equiv). The mixture was stirred
under nitrogen at 60 ꢀC for 15 h. The crude product was purified by
flash column chromatography (SiO2; gradient: 1:3/3:7/2:3
dichloromethane/hexanes) to afford 8c as a white solid (21 mg, 56%
4.6.8. 2-Phenylbenzofuran (7b). Prepared according to General
procedure C using Pd(OAc)2 (0.9 mg, 0.0045 mmol, 5 mol %), SPhos
(3.1 mg, 0.0090 mmol, 10 mol %), 3.0 M aqueous K3PO4 (0.23 mL,
7.5 equiv of base), and chlorobenzene (9 mL, 0.090 mmol, 1 equiv).
The mixture was stirred under nitrogen at 60 ꢀC for 4.5 h. The crude
product was purified by flash column chromatography (SiO2;
hexanes) to afford 7b as a white solid (12 mg, 69% over two steps).
over two steps). 1H NMR (400 MHz, acetone-d6,
d ppm): 8.02 (1H, d,
J¼7.6 Hz), 7.87 (2H, d, J¼8.4 Hz), 7.71 (1H, s), 7.58 (2H, d, J¼8.0 Hz),
7.35 (5H, m), 7.23 (1H, t, J¼7.2 Hz), 6.79 (1H, s), 2.33 (3H, s). 13C NMR
1H NMR (400 MHz, CDCl3,
d
ppm): 7.89 (2H, d, J¼7.0 Hz), 7.61 (1H, d,
(400 MHz, acetone-d6, d ppm): 146.9, 136.5, 136.2, 132.4, 132.1, 131.4,
J¼7.8 Hz), 7.55 (1H, d, J¼8.2 Hz), 7.48 (2H, t, J¼7.3 Hz), 7.38 (1H, t,
129.1,128.3,128.0,127.5,125.9,125.6,124.7,124.6,110.6,101.4, 21.9. 19F
J¼7.5 Hz), 7.23e7.33 (2H, m), 7.06 (1H, s). 13C NMR (400 MHz, CDCl3,
NMR (400 MHz, acetone-d6,
d
ppm): ꢂ62.16. HRMS: calcd: 415.0854
d
ppm): 156.1, 155.1, 147.9, 130.6, 129.4, 129.0, 128.7, 125.3, 124.4,
(M)þ, found: 415.0855.
123.5, 121.6, 121.1, 111.5, 103.9, 101.5. HRMS: calcd: 194.0732 (M)þ,
found: 194.0731.
4.6.14. 1-(40-Methoxybenzylidene)-1,3-dihydroisobenzofuran
(9). Prepared according to General procedure C using Pd(OAc)2
(1.8 mg, 0.009 mmol, 5 mol %), SPhos (6.2 mg, 0.018 mmol,
10 mol %), 3.0 M aqueous K3PO4 (0.46 mL, 7.5 equiv of base), and 4-
bromoanisole (0.023 mL, 0.090 mmol, 1 equiv). The mixture was
stirred under nitrogen at 60 ꢀC for 15 h. The crude product was
purified by flash column chromatography (SiO2; gradient:
hexanes/1:4/3:7/2:3 dichloromethane/hexanes) to afford 9a
as a white solid (11.3 mg, 53% over two steps). 1H NMR (400 MHz,
4.6.9. 2-(40-Trifluoromethylphenyl)benzofuran (7c). Prepared accord-
ing to General procedure C using Pd(OAc)2 (0.9 mg, 0.0045 mmol,
5 mol %), SPhos (3.1 mg, 0.0090 mmol, 10 mol %), 3.0 M aqueous
K3PO4 (0.23 mL, 7.5 equiv of base), and 4-chlorobenzotrifluoride
(0.012 mL, 0.090 mmol, 1 equiv). The mixture was stirred under
nitrogen at 60 ꢀC for 5 h. The crude product was purified by flash
column chromatography (SiO2; hexanes) to afford 7c as a white solid
(11.3 mg, 48% over two steps). 1H NMR (400 MHz, CDCl3,
d
ppm):
CD2Cl2,
(3H, m), 6.88 (2H, d, J¼6.8 Hz), 5.92 (1H, s), 5.51 (2H, s), 3.81 (3H, s).
13C NMR (400 MHz, CD2Cl2,
ppm): 157.2, 154.5, 138.8, 134.5, 128.9,
d
ppm): 7.67 (2H, d, J¼8.8 Hz), 7.56 (1H, d, J¼6.8 Hz), 7.36
8.00 (2H, d, J¼8.4 Hz), 7.72 (2H, d, J¼8.0 Hz), 7.64 (1H, d, J¼7.2 Hz),
7.56 (1H, d, J¼8.0 Hz), 7.27 (1H, t, J¼7.6 Hz), 7.20 (1H, s). 13C NMR
d
(400 MHz, CDCl3,
d
ppm): 129.4, 128.9, 126.3, 125.7, 125.5, 124.0,
128.5, 128.1, 127.7, 127.2, 120.9, 119.2, 113.8, 113.4, 95.2, 74.5, 54.8.
HRMS: calcd: 238.0994 (M)þ, found: 238.0993.
123.8, 122.1, 121.9, 121.1, 111.8, 103.9. HRMS: calcd: 262.0605 (M)þ,
found: 262.0607.
Acknowledgements
4.6.10. 2-(40-tert-Butylphenyl)benzofuran (7d). Prepared in the
same way as 7a starting with 39.5 mg of the precursor phenol, but
Catalyst C was used instead of Catalyst A. Upon purification, 7d was
afforded as a white solid (13.7 mg, 38% over two steps). Charac-
terization data was identical to 7a (i.e., same compound).
We gratefully acknowledge NIHGMS (RO1 GM073932) and
Amgen for financial support. G.W.A. thanks the National Council
for Scientific and Technological Development (CNPq)-Brazil for
a postdoctoral fellowship. We also thank Professor Martin D.
Burke and his group at the University of Illinois, Urbana-
Champaign for their generous gift of ethynyl MIDA boronate
and Johnson Matthey for a donation of AuCl3. Gold catalysts B and
C were provided by Dr. William E. Brenzovich.
4.6.11. 1-Tosyl-2-(40-tert-butylphenyl)indole (8a). Prepared accord-
ing to General procedure C using Pd(OAc)2 (0.9 mg, 0.0045 mmol,
5 mol %), SPhos (3.1 mg, 0.0090 mmol, 10 mol %), 3.0 M aqueous
K3PO4 (0.23 mL, 7.5 equiv of base), and 1-bromo-4-tert-butylben-
zene (0.014 mL, 0.090 mmol, 1 equiv). The mixture was stirred
under nitrogen at 60 ꢀC for 5 h. The crude product was purified by
flash column chromatography (SiO2; gradient: 1:3/2:3/1:1
dichloromethane/hexanes) to afford 8a as a white solid (19.3 mg,
References and notes
1. (a) De Luca, L.; Nieddu, G.; Porcheddu, A.; Giacomelli, G. Curr. Med. Chem. 2009,
58% over two steps). 1H NMR (400 MHz, CD2Cl2,
J¼8.4 Hz), 7.25e7.50 (5H), 7.08 (2H, d, J¼8.4 Hz), 2.29 (3H, s), 1.40
(9H, s). 13C NMR (400 MHz, CD2Cl2,
ppm): 152.3, 145.4, 130.4,
d ppm): 8.23 (1H, d,
€
16, 1e20; (b) Brase, S.; Gil, C.; Knepper, K. Bioorg. Med. Chem. 2002, 10,
2415e2437; (c) Mor, M.; Spadoni, G.; Di Giacomo, B.; Diamantini, G.; Bedini, A.;
Tarzia, G.; Plazzi, P. V.; Rivara, S.; Nonno, R.; Lucini, V.; Pannacci, M.; Fraschini,
F.; Stankov, B. M. Bioorg. Med. Chem. 2001, 10, 1045e1057; (d) Horton, D. A.;
Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103, 893e930; (e) Engler, T. A.;
LaTessa, K. O.; Iyengar, R.; Chai, W.; Agrios, K. Bioorg. Med. Chem. 1996, 4,
1755e1769; (f) Dai, J. R.; Hallock, Y. F.; Cardellina, J. H.; Boyd, M. J. Nat. Prod.
1998, 61, 351e353; (g) Diyasena, M. N. C.; Sotheeswaran, S.; Surendrakumar, S.;
Balasubramanian, S.; Bokel, M.; Kraus, W. J. Chem. Soc., Perkin Trans. 1 1985,
1807e1809; (h) Dean, F. M. In The Total Synthesis of Natural Products; ApSimon, J.
, Ed.; Wiley: New York, NY, 1973; Vol. 1.
2. (a) Katritzky, A. R.; Li, J.; Stevens, C. V. J. Org. Chem. 1995, 60, 3401e3404; (b)
Kraus, G. A.; Guo, H. Org. Lett. 2008, 10, 3061e3063; (c) Taber, D. F.; Tian, W. J.
Am. Chem. Soc. 2006, 128, 1058e1059; (d) Fang, Y.-Q.; Lautens, M. Org. Lett.
2005, 7, 3549e3552; (e) Gribble, G. W. J. Chem. Soc., Perkin Trans. 1 2000, 7,
1045e1075; (f) Yue, D.; Yao, T.; Larock, R. C. J. Org. Chem. 2006, 71, 62e69; (g)
Kumar, M. P.; Liu, R.-S. J. Org. Chem. 2006, 71, 4951e4955.
d
129.8, 128.9, 127.2, 125.2, 125.0, 124.8, 124.5, 121.1, 117.0, 114.0, 35.2,
31.6, 21.8. HRMS: calcd: 403.1606 (M)þ, found: 403.1612.
4.6.12. 1-Tosyl-2-phenylindole (8b). Prepared according to General
procedure C using Pd(OAc)2 (0.9 mg, 0.0045 mmol, 5 mol %), SPhos
(3.1 mg, 0.0090 mmol, 10 mol %), 3.0 M aqueous K3PO4 (0.23 mL,
7.5 equiv of base), and chlorobenzene (9.2 mL, 0.090 mmol, 1 equiv).
The mixture was stirred under nitrogen at 60 ꢀC for 5 h. The crude
product was purified by flash column chromatography (SiO2; gra-
dient: 1:3/3:7/2:3 dichloromethane/hexanes) to afford 8b as